Fw: [drugwar] Wire: OPED: Arrest MS, Not Patients

Preston Peet ptpeet at nyc.rr.com
Wed Sep 24 14:03:51 EDT 2003

----- Original Message ----- 
From: "Richard Lake" <rlake at mapinc.org>
To: <drugwar at mindvox.com>
Sent: Wednesday, September 24, 2003 10:00 AM
Subject: [drugwar] Wire: OPED: Arrest MS, Not Patients

> URL: http://www.mapinc.org/drugnews/v03/n1447/a11.html
> Pubdate: Mon, 21 Sep 2003
> Source: United Press International (Wire)
> Copyright: 2003 United Press International
> Author: Paul Armentano
> Note: The author is a senior policy analyst for the NORML Foundation, a
> group that supports the liberalization of America's marijuana laws, in
> Washington.
> Also: The first photos of the march on Washington are on line at
> http://www.cheryldcmemorial.org/92203_ms_pts_ms_soc.htm - more to follow.
> Bookmark: http://www.mapinc.org/mmj.htm (Cannabis - Medicinal)
> Bookmark: http://www.mapinc.org/people/Cheryl+Miller
> WASHINGTON, Sept. 22 (UPI) -- A potential breakthrough in the treatment of
> multiple sclerosis could lie on the horizon, and it may come from an
> source: marijuana.
> According to clinical findings published in the most recent issue of the
> journal Brain, cannabinoids (ingredients in marijuana) offer
> against allergic encephalomyelitis (EAE), an animal model of MS. After
> analyzing the findings, authors at London's Institute of Neurology
> "In addition to symptom management, cannabis may also slow down the
> neurodegenerative processes that ultimately lead to chronic disability in
> multiple sclerosis and probably other diseases."
> Their statement gives hope to the estimated 350,000 patients in the United
> States living with MS, a debilitating and sometimes fatal disorder of the
> central nervous system. Although previous human studies have indicated
that pot
> may provide therapeutic relief to common symptoms of MS such as muscle
> tremor, and incontinence, the London study is one of the first to indicate
> cannabinoids may also potentially stave off the disease.
> Unfortunately, far too many politicians remain in the dark about
> medicinal value, with many in Congress opting to punish medicinal pot
> rather than support them. In an effort to change this view, dozens of MS
> patients who use marijuana therapeutically are descending on Washington
> week to bring needed attention to the medicinal marijuana issue. Patients
> be holding a candlelight vigil in front of the Supreme Court in honor of
> Miller -- a longtime medical marijuana activist who died of MS-related
> complications in June -- as well as a press conference with various
members of
> Congress in support of House Bill 2233, the "States' Rights to Medical
> Marijuana Act."
> "Throughout much of her life, Cheryl risked arrest and jail to use the
> medication that alleviated her suffering," remembers her husband Jim
> organizer of the patient march on Washington. "I hope that by bringing
> attention to the plight of my late wife Cheryl, I can hasten the day when
> marijuana will be made available so that others are no longer needlessly
> to suffer with pain or risk arrest."
> Further research on the use of marijuana as a medicine is forthcoming.
> Nevertheless, it appears that many MS sufferers have already learned what
> scientific community is just now discovering. For example, a recent
> survey of MS patients found that 43 percent of respondents used marijuana
> therapeutically. Among them, nearly three quarters said that pot mitigated
> their spasms, and more than half said it alleviated their pain.
> Clinical data published in the spring edition of the journal Clinical
> Rehabilitation affirmed these perceptions. The study, performed by
> at Oxford University, found that MS patients administered whole-plant
> extracts experienced improved pain relief, bladder control, and spasticity
> compared to placebo. As a result, these pot extracts are now being
evaluated by
> the UK's National Institute for Clinical Excellence, which is expected to
> a decision regarding the drugs' legalization this fall.
> Meanwhile, a survey published last month in the Canadian Journal of
> Neurological Sciences reported that 96 percent of Canadian MS patients
> that marijuana is therapeutically useful for treating the disease. Of
those who
> admitted using marijuana medicinally, the majority found it to be
> particularly in the treatment of chronic pain, spasticity and depression.
> With scientific evidence mounting and large numbers of MS sufferers
> using marijuana medicinally, it's time to for Congress to acknowledge
> emerging role as a therapeutic agent, and stand up for the rights of
> who ease their pain and suffering through the use of marijuana.
> - --- 
>   [           Moderated by: Preston Peet |
.drugwar.com           ]
>   |          -=/[ To Subscribe: drugwar-subscribe at mindvox.com ]/=-
>   |             To Unsubscribe: drugwar-unsubscribe at mindvox.com
>   [   DrugWar List in Digest Format:
ugwar-digest-subscribe at mindvox.com   ]

More information about the Ibogaine mailing list